Allan Seibert

1.8k total citations
18 papers, 467 citations indexed

About

Allan Seibert is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Allan Seibert has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Applied Microbiology and Biotechnology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Allan Seibert's work include Antibiotic Use and Resistance (5 papers), Patient Satisfaction in Healthcare (3 papers) and Pneumonia and Respiratory Infections (2 papers). Allan Seibert is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Patient Satisfaction in Healthcare (3 papers) and Pneumonia and Respiratory Infections (2 papers). Allan Seibert collaborates with scholars based in United States, Kuwait and Netherlands. Allan Seibert's co-authors include Dianne M. O’Dell, Kenneth Chinsky, Katharine Knobil, Christopher Kalberg, Antonio Anzueto, Amanda Emmett, Greg Feldman, Gary T. Ferguson, Glenn Crater and G. Hempelmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care Medicine and The American Journal of Gastroenterology.

In The Last Decade

Allan Seibert

13 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan Seibert United States 6 175 142 117 89 70 18 467
J. Jones United Kingdom 8 54 0.3× 92 0.6× 98 0.8× 247 2.8× 47 0.7× 15 587
Andrew W. Shih Canada 13 40 0.2× 56 0.4× 78 0.7× 125 1.4× 27 0.4× 63 563
Ejler Ejlersen Denmark 13 45 0.3× 72 0.5× 32 0.3× 75 0.8× 53 0.8× 23 515
John S. Giuliano United States 15 205 1.2× 356 2.5× 67 0.6× 19 0.2× 10 0.1× 48 871
Luis Rojas Chile 16 59 0.3× 31 0.2× 18 0.2× 62 0.7× 26 0.4× 48 636
Denise Kelley United States 13 52 0.3× 106 0.7× 12 0.1× 21 0.2× 50 0.7× 20 335
Márcia L. Zucker United States 10 31 0.2× 64 0.5× 65 0.6× 16 0.2× 52 0.7× 27 355
Amy Morris United States 12 57 0.3× 112 0.8× 17 0.1× 41 0.5× 16 0.2× 31 470
Diego Martínez‐Urbistondo Spain 12 70 0.4× 127 0.9× 53 0.5× 10 0.1× 9 0.1× 40 498
Jesús Aibar Spain 12 45 0.3× 85 0.6× 9 0.1× 37 0.4× 42 0.6× 31 331

Countries citing papers authored by Allan Seibert

Since Specialization
Citations

This map shows the geographic impact of Allan Seibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Seibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Seibert more than expected).

Fields of papers citing papers by Allan Seibert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Seibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Seibert. The network helps show where Allan Seibert may publish in the future.

Co-authorship network of co-authors of Allan Seibert

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Seibert. A scholar is included among the top collaborators of Allan Seibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Seibert. Allan Seibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Olson, Jared, Adam L. Hersh, C. Dustin Waters, et al.. (2025). Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system. Infection Control and Hospital Epidemiology. 47(2). 180–188.
2.
Patel, Sanjay V., et al.. (2024). West Nile Virus Meningoencephalitis in Liver Transplantation. A7041–A7041.
3.
Jenkins, Timothy C, Joshua Epstein, Adam L. Hersh, et al.. (2024). Interventions to de-implement unnecessary antibiotic prescribing for ear infections (DISAPEAR Trial): protocol for a cluster-randomized trial. BMC Infectious Diseases. 24(1). 126–126. 1 indexed citations
4.
Seibert, Allan, Whitney R. Buckel, Payal Patel, et al.. (2023). Beyond antibiotic prescribing rates: first-line antibiotic selection, prescription duration, and associated factors for respiratory encounters in urgent care. SHILAP Revista de lepidopterología. 3(1). e146–e146. 1 indexed citations
5.
Seibert, Allan, Adam L. Hersh, Payal Patel, et al.. (2023). Impact of an antibiotic stewardship initiative on urgent-care respiratory prescribing across patient race, ethnicity, and language. Infection Control and Hospital Epidemiology. 45(4). 530–533.
6.
Stenehjem, Edward, Park W. Willis, Allan Seibert, et al.. (2023). Implementation of an Antibiotic Stewardship Initiative in a Large Urgent Care Network. JAMA Network Open. 6(5). e2313011–e2313011. 21 indexed citations
7.
Imlay, Hannah, Allan Seibert, & Kimberly E. Hanson. (2023). Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation. Transplant Infectious Disease. 25(2). e14020–e14020. 5 indexed citations
8.
Seibert, Allan, Edward Stenehjem, Park W. Willis, et al.. (2022). Rapid streptococcal pharyngitis testing and antibiotic prescribing before and during the coronavirus disease 2019 (COVID-19) pandemic. SHILAP Revista de lepidopterología. 2(1). e80–e80. 4 indexed citations
9.
Skedros, John G., et al.. (2021). Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection (Klebsiella oxytoca and Group B Streptococcus). SHILAP Revista de lepidopterología. 2021. 1–6. 2 indexed citations
10.
Zadravecz, Frank J., et al.. (2020). Novel coronavirus 2019 (COVID‐19): Emergence and implications for emergency care. Journal of the American College of Emergency Physicians Open. 1(2). 63–69. 61 indexed citations
11.
Ahmed, Zunirah, et al.. (2018). An Unusual Cause of Hyperammonemic Encephalopathy. The American Journal of Gastroenterology. 113(Supplement). S1274–S1274.
12.
Ahmed, Zunirah, et al.. (2018). Response of Bortezomib Chemotherapy in Hepatic Amyloidosis. Journal of Investigative Medicine High Impact Case Reports. 6. 2735225231–2735225231. 2 indexed citations
13.
Seibert, Allan, et al.. (2017). 582: A RARE CAUSE OF DISSEMINATED HISTOPLASMOSIS: IDIOPATHIC CD4 LYMPHOPENIA. Critical Care Medicine. 46(1). 276–276. 1 indexed citations
14.
Anzueto, Antonio, Gary T. Ferguson, Greg Feldman, et al.. (2009). Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes. COPD Journal of Chronic Obstructive Pulmonary Disease. 6(5). 320–329. 135 indexed citations
15.
Squillacote, Michael E., Jiwei Chen, & Allan Seibert. (2009). A Silicone Septum as a Connector for Serially Coupled Capillary GC Columns. Chromatographia. 69(7-8). 771–773. 4 indexed citations
16.
Abraham, Edward, Konrad Reinhart, Petr Svoboda, et al.. (2001). Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Critical Care Medicine. 29(11). 2081–2089. 193 indexed citations
17.
Haynes, Johnson, Allan Seibert, John B. Bass, & A. E. Taylor. (1990). U74500A inhibition of oxidant-mediated lung injury. American Journal of Physiology-Heart and Circulatory Physiology. 259(1). H144–H148. 37 indexed citations
18.
Haynes, Johnson, Allan Seibert, Aarti R. Shah, & A. E. Taylor. (1990). Normal versus sickle red blood cells: hemodynamic and permeability characteristics in reperfusion lung injury.. PubMed. 1(3). 62–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Jones Breakdown of academic impact, for papers by Andrew W. Shih Breakdown of academic impact, for papers by Ejler Ejlersen Breakdown of academic impact, for papers by John S. Giuliano Breakdown of academic impact, for papers by Luis Rojas Breakdown of academic impact, for papers by Denise Kelley Breakdown of academic impact, for papers by Márcia L. Zucker Breakdown of academic impact, for papers by Amy Morris Breakdown of academic impact, for papers by Diego Martínez‐Urbistondo Breakdown of academic impact, for papers by Jesús Aibar
Rankless by CCL
2026